CTEV News & Events

Claritev rallies after commenting on last week's Capitol Forum report

Claritev disclosed that nn article published on Thursday, May 14, 2026 alleges that "DOJ launches criminal antitrust probe into Claritev." In August of 2024, the company said it received a confidential grand jury subpoena issued by the Antitrust Division of the Department of Justice in connection with an investigation regarding health insurance. "The Company has been cooperating fully with the DOJ and at no point in the subsequent two years has the DOJ informed the Company that it is the target of an investigation. We remain focused on working with clients and partners across the entire healthcare ecosystem to make healthcare more transparent, accessible, and affordable for all consumers," it added.

The Justice Department's antitrust division has launched a criminal price-fixing investigation into Claritev, a pricing intermediary that major health insurers use to set reimbursement rates for out-of-network medical claims, Capitol Forum reported last week, citing sources familiar with the matter.

The shares are up 20%, or $2.78, to $16.65 in midday trading.